Hemodynamic Impact of Hyperbaric Versus Isobaric for Spinal Anesthesia During Cesarean Delivery
NCT ID: NCT02802683
Last Updated: 2016-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
72 participants
INTERVENTIONAL
2015-09-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Norepinephrine and Phenylephrine for Maternal Cardiac Output During Spinal Anesthesia for Elective Cesarean Delivery
NCT02969239
Spinal Marginally Hyperbaric Ropivacaine for Cesarean Delivery
NCT03142880
Predictive Hemodynamic Monitoring During Elective Cesarean Section
NCT06729827
Crystalloid Versus Colloid Rapid Co-load for Cesarean Delivery Under Spinal Anesthesia
NCT03729076
Cardiac Output Changes During Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Cesarean Section
NCT02737813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"BUPI","P"
patients who received hyperbaric bupivacaine and continous infusion of phenylephrine
Bupivacaine
spinal anesthesia with hyperbaric bupivacaine
Phenylephrine
continous infusion of phenylephrine
"BUPI","N"
patients who received hyperbaric bupivacaine and continous infusion of normal saline
Bupivacaine
spinal anesthesia with hyperbaric bupivacaine
normal saline
continous infusion of normal saline
"LEVO","P"
patients who received isobaric levobupivacaine and continous infusion of phenylephrine
Levobupivacaine
spinal anesthesia with isobaric levobupivacaine
Phenylephrine
continous infusion of phenylephrine
"LEVO","N"
patients who received isobaric levobupivacaine and continous infusion of normal saline
Levobupivacaine
spinal anesthesia with isobaric levobupivacaine
normal saline
continous infusion of normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
spinal anesthesia with hyperbaric bupivacaine
Levobupivacaine
spinal anesthesia with isobaric levobupivacaine
Phenylephrine
continous infusion of phenylephrine
normal saline
continous infusion of normal saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients who have pre-eclampsia
* patients who have heart disease
* patients who fetal distress is suspicious
19 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jae-Hyon Bahk, MD, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bahk
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital Seoul, Korea, Republic of
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JHBahk_C/S
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.